DK1790357T3 - Peroralt indgivelig antimikrobiel sammensætning - Google Patents

Peroralt indgivelig antimikrobiel sammensætning

Info

Publication number
DK1790357T3
DK1790357T3 DK05782960T DK05782960T DK1790357T3 DK 1790357 T3 DK1790357 T3 DK 1790357T3 DK 05782960 T DK05782960 T DK 05782960T DK 05782960 T DK05782960 T DK 05782960T DK 1790357 T3 DK1790357 T3 DK 1790357T3
Authority
DK
Denmark
Prior art keywords
antimicrobial composition
composition
lactulose
orally administered
antibiotic
Prior art date
Application number
DK05782960T
Other languages
English (en)
Inventor
Nikolai Alexandrovich Kiselev
Dmitry Sergeevich Chicherin
Original Assignee
Nikolai Alexandrovich Kiselev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1790357(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nikolai Alexandrovich Kiselev filed Critical Nikolai Alexandrovich Kiselev
Application granted granted Critical
Publication of DK1790357T3 publication Critical patent/DK1790357T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05782960T 2004-08-30 2005-08-25 Peroralt indgivelig antimikrobiel sammensætning DK1790357T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения
PCT/RU2005/000434 WO2006025767A2 (fr) 2004-08-30 2005-08-25 Composition antimicrobienne destinee a une administration perorale

Publications (1)

Publication Number Publication Date
DK1790357T3 true DK1790357T3 (da) 2009-02-02

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05782960T DK1790357T3 (da) 2004-08-30 2005-08-25 Peroralt indgivelig antimikrobiel sammensætning

Country Status (21)

Country Link
US (1) US8231871B2 (da)
EP (1) EP1790357B1 (da)
JP (1) JP5062480B2 (da)
CN (1) CN101031321B (da)
AT (1) ATE410185T1 (da)
AU (1) AU2005280704B2 (da)
BR (1) BRPI0514708A (da)
CA (1) CA2620919C (da)
DE (1) DE602005010280D1 (da)
DK (1) DK1790357T3 (da)
EA (1) EA200700357A1 (da)
ES (1) ES2314708T3 (da)
MX (1) MX2007002291A (da)
NZ (1) NZ554212A (da)
PL (1) PL1790357T3 (da)
PT (1) PT1790357E (da)
RU (1) RU2284832C2 (da)
TR (1) TR200703565T1 (da)
UA (1) UA85608C2 (da)
WO (1) WO2006025767A2 (da)
ZA (1) ZA200704449B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
CN101128206A (zh) * 2005-01-21 2008-02-20 沃纳奇尔科特公司 固体剂型形式的四环素类金属络合物
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии
RU2325166C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и лактулозы для профилактики энтеральных дисбиозов в процессе антибиотикотерапии
BRPI0822359A2 (pt) * 2008-03-18 2015-07-14 Aleksander Vladimirovich Dikovskiy Composição farmacêutica de antibióticos e prebióticos para prevenir e tratar disbiose durante terapia antibacteriana
EP2266582B1 (en) * 2008-03-18 2015-04-29 Dikovskiy, Aleksander Vladimirovich Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics
RU2415684C2 (ru) * 2008-04-16 2011-04-10 Александр Владимирович Диковский Фармацевтическая композиция для лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц и способ лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц
EP2994532B1 (en) 2013-05-07 2017-11-15 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
ZA891978B (en) * 1988-03-18 1990-01-31 Duphar Int Res Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
KR100388569B1 (ko) * 1994-04-22 2003-10-11 야마노우치세이야쿠 가부시키가이샤 결장특이적약물방출용경구약제학적제제
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
WO2000052037A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
ATE314091T1 (de) * 1999-06-09 2006-01-15 Mochida Pharm Co Ltd System für wirkstofffreisetzung im unteren verdauungstrakt

Also Published As

Publication number Publication date
JP5062480B2 (ja) 2012-10-31
ES2314708T3 (es) 2009-03-16
BRPI0514708A (pt) 2008-06-24
MX2007002291A (es) 2008-02-12
AU2005280704A1 (en) 2006-03-09
ZA200704449B (en) 2008-08-27
EP1790357B1 (en) 2008-10-08
CA2620919A1 (en) 2006-03-09
EP1790357A4 (en) 2007-11-07
EA010199B1 (ru) 2008-06-30
US8231871B2 (en) 2012-07-31
JP2008511622A (ja) 2008-04-17
ATE410185T1 (de) 2008-10-15
RU2004126203A (ru) 2006-02-10
WO2006025767A8 (en) 2007-04-05
CN101031321B (zh) 2010-12-15
WO2006025767A2 (fr) 2006-03-09
PT1790357E (pt) 2008-12-31
DE602005010280D1 (de) 2008-11-20
UA85608C2 (ru) 2009-02-10
NZ554212A (en) 2009-08-28
WO2006025767A3 (fr) 2006-08-17
TR200703565T1 (tr) 2007-08-21
EP1790357A2 (en) 2007-05-30
CA2620919C (en) 2014-10-14
RU2284832C2 (ru) 2006-10-10
AU2005280704B2 (en) 2010-10-07
PL1790357T3 (pl) 2009-03-31
EA200700357A1 (ru) 2008-06-30
US20070254023A1 (en) 2007-11-01
CN101031321A (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
ZA200704449B (en) Perorally administrable antimicrobial composition
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2007070677A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO1997015269A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
WO2002043765A3 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
WO2005041934A3 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2006102446A3 (en) Multi-particulate, modified-released colonic composition
CA2285266A1 (en) Extended release formulations of erythromycin derivatives
WO2003053350A3 (en) Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
CA2315261A1 (en) Oral pharmaceutical extended release dosage form
CA2115381A1 (en) Rifaximin and Pharmaceutical Compositions Containing It in the Treatment of Gastric Dyspepsia Caused by Helicobacter Pylori
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
WO2008039406A3 (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
WO2002064132A3 (en) Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2010046933A3 (en) Pharmaceutical compositions of taste-masked linezolid
WO2008005352A3 (en) Solid dose formulations of a thrombin receptor antagonist
ES2390226T3 (es) Tratamiento de enfermedades infecciosas
WO2002096354A3 (en) Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
CN107427462B (zh) 固态分散体
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
WO2008009589A3 (en) Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
WO2005065685A8 (en) Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
BR0115206A (pt) Composições hidroliticamente instáveis